DK
Daniel L Kisner

Daniel L Kisner insider trades: Zynerba Pharmaceuticals (ZYNE) stock buys and sales

Zynerba Pharmaceuticals Last trade Jun 14, 2023 68 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2008
7
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Daniel reports to the SEC

and 1 more company

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 14, 2023ZYNE↓ Sell$40
Jun 14, 2022ZYNE↓ Sell$40
Jul 21, 2020ONCT↑ Buy$24K
Apr 8, 2015CNAT↑ Buy$23K
Oct 30, 2013DVAX↑ Buy$11K
Jun 3, 2008CALP↓ Sell$4K
Jun 2, 2008CALP↓ Sell$30K
May 19, 2008CALP↓ Sell$58K
May 13, 2008CALP↓ Sell$2K
May 6, 2008CALP↓ Sell$8K
May 5, 2008CALP↓ Sell$57K
May 1, 2008CALP↓ Sell$21K
Apr 16, 2008CALP↓ Sell$19K
Apr 15, 2008CALP↓ Sell$72K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Daniel L Kisner's insider trades

Daniel L Kisner is an insider at Zynerba Pharmaceuticals (ZYNE). Since Apr 15, 2008, Daniel has reported 3 open-market purchases worth $58K and 11 sales worth $273K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (52 filings), option exercises (10 filings), other transactions (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZYNE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.